Form 4: Equifax CEO Mark Begor Reports Stock and Option Awards in Form 4 Filing
SEC Form 4 Filing
Equifax CEO Mark Begor reports the acquisition of stock and option awards, including restricted stock units and stock options, in a recent Form 4 filing with the SEC.
Summary
- Equifax CEO Mark Begor filed a Form 4 with the SEC on February 12, 2025.
- The filing reports changes in beneficial ownership of Equifax securities.
- Begor acquired 13,524 shares of common stock through an annual equity grant, vesting on February 10, 2028.
- He also acquired stock options to buy 23,519 shares at $303.48 and 21,668 shares at $278.19, both exercisable between February 10, 2028, and February 10, 2033.
- Following the reported transactions, Begor directly owns 122,929 shares of common stock.
- He also indirectly owns shares through various grantor retained annuity trusts (GRATs).
- These include 43,382 shares in a 2-Year 2023 GRAT, 20,025 shares in a 2-year Feb 2024 GRAT, 24,125 shares in a 2-yr Jul 2024 GRAT, 24,225 shares in a 3-yr Jul 2024 GRAT and 12,333 shares in a 4-Year 2021 GRAT.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The CEO receiving stock and option awards is generally a positive sign, but it's an expected part of their compensation package.
Positives
- The acquisition of stock and options by the CEO could be seen as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements about the company's future performance, but the vesting of restricted stock units in 2028 and the expiration of stock options in 2033 suggest a long-term incentive structure for the CEO.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The filing indicates the CEO's ongoing investment in the company.
Stakeholder Impact
- The reported transactions may influence investor sentiment regarding the CEO's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 02/10/2025 | Date of earliest transaction and annual equity grant. |
| 02/10/2028 | Vesting date for the restricted stock units. |
| 02/10/2028 | Earliest exercisable date for stock options. |
| 02/10/2033 | Expiration date for stock options. |
| 02/12/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.